This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

North Shore-LIJ Extends Allscripts Outsourcing Agreement Through 2020

CHICAGO, July 9, 2013 /PRNewswire/ -- Allscripts (NASDAQ: MDRX) announced today that the North Shore-LIJ Health System has extended its relationship for managed IT services. The five-year extension builds on a long-standing partnership between the two companies and is expected to result in more than $400 million in incremental revenue to Allscripts over the life of the contract.

"Choosing the right partners is an important part of our commitment to deliver compassionate medical care in a safe and comfortable environment," said Michael J Dowling, President and Chief Executive Officer, North Shore-LIJ. "Allscripts has proven they have the expertise to help us cross the chasm to value-based care."

"At North Shore-LIJ, we are committed to using leading-edge technology as an accelerator to deliver the best patient care," said John L. Bosco, Senior Vice President and Chief Information Officer at North Shore-LIJ. "Our investments in Allscripts, in both solutions and managed services, better enable caregivers to focus on what they need to – taking care of patients." 

North Shore-LIJ plays a key role in meeting the health and wellness needs of millions of people throughout the New York metropolitan area, and in improving the technology and innovation that will help strengthen the quality of health care in the region.  To support those efforts, Allscripts will collaborate with North Shore-LIJ in establishing an Innovation Lab to: accelerate technological advancements in Allscripts solutions and tools; collaborate with North Shore-LIJ physicians to create improved health-care technology solutions; and deliver solutions that can rapidly respond to changes in the region's health care markets. 

In addition to fully managing IT Services for North Shore-LIJ, Allscripts technology and solutions already deployed in the network include Sunrise Clinical Manager, Enterprise Electronic Health Record and Care Management.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.37 1.80%
FB $117.91 -0.56%
GOOG $695.59 -0.38%
TSLA $236.99 -2.00%
YHOO $36.14 -1.10%


Chart of I:DJI
DOW 17,760.49 -130.67 -0.73%
S&P 500 2,063.36 -18.07 -0.87%
NASDAQ 4,773.5830 -44.0110 -0.91%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs